ATE525396T1 - Slo2 und slo4, neue kaliumkanal-proteine aus menschlichem gehirn - Google Patents
Slo2 und slo4, neue kaliumkanal-proteine aus menschlichem gehirnInfo
- Publication number
- ATE525396T1 ATE525396T1 AT01964104T AT01964104T ATE525396T1 AT E525396 T1 ATE525396 T1 AT E525396T1 AT 01964104 T AT01964104 T AT 01964104T AT 01964104 T AT01964104 T AT 01964104T AT E525396 T1 ATE525396 T1 AT E525396T1
- Authority
- AT
- Austria
- Prior art keywords
- slo2
- potassium channel
- channel proteins
- slo4
- human brain
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Hospice & Palliative Care (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24911200P | 2000-11-15 | 2000-11-15 | |
US09/921,159 US7041494B2 (en) | 2000-11-15 | 2001-08-01 | DNA encoding Slo2 and Slo4, potassium channel |
PCT/US2001/025701 WO2002040649A1 (en) | 2000-11-15 | 2001-08-15 | Slo2 and slo4, novel potassium channel proteins from human brain |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE525396T1 true ATE525396T1 (de) | 2011-10-15 |
Family
ID=26939832
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01964104T ATE525396T1 (de) | 2000-11-15 | 2001-08-15 | Slo2 und slo4, neue kaliumkanal-proteine aus menschlichem gehirn |
Country Status (7)
Country | Link |
---|---|
US (4) | US7041494B2 (de) |
EP (2) | EP2295454A1 (de) |
JP (1) | JP2005507633A (de) |
AT (1) | ATE525396T1 (de) |
AU (2) | AU8499501A (de) |
CA (1) | CA2428350A1 (de) |
WO (1) | WO2002040649A1 (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1505150A1 (de) * | 2002-05-14 | 2005-02-09 | Takeda Pharmaceutical Company Limited | Neue proteine und deren dnas |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2307062A1 (en) * | 1997-10-22 | 1999-04-29 | Washington University | A ph sensitive potassium channel in spermatocytes |
US20030143676A1 (en) * | 1999-03-25 | 2003-07-31 | Genesis Research And Development Corporation Limited | Fibroblast growth factor receptors and methods for their use |
US6972187B2 (en) * | 2000-05-12 | 2005-12-06 | Millennium Pharmaceuticals, Inc. | OAT5 molecules and uses therefor |
US20040009474A1 (en) * | 2000-05-24 | 2004-01-15 | Leach Martin D. | Novel human polynucleotides and polypeptides encoded thereby |
US20020048787A1 (en) * | 2000-06-14 | 2002-04-25 | Ming-Hui Wei | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
WO2002012340A2 (en) * | 2000-08-03 | 2002-02-14 | Incyte Genomics, Inc. | Transporters and ion channels |
JP2005518185A (ja) * | 2001-06-04 | 2005-06-23 | キュラジェン コーポレイション | 新規タンパク質およびそれをコード化する核酸 |
-
2001
- 2001-08-01 US US09/921,159 patent/US7041494B2/en not_active Expired - Fee Related
- 2001-08-15 EP EP10176436A patent/EP2295454A1/de not_active Withdrawn
- 2001-08-15 AU AU8499501A patent/AU8499501A/xx active Pending
- 2001-08-15 EP EP01964104A patent/EP1334178B1/de not_active Expired - Lifetime
- 2001-08-15 CA CA002428350A patent/CA2428350A1/en not_active Abandoned
- 2001-08-15 AT AT01964104T patent/ATE525396T1/de not_active IP Right Cessation
- 2001-08-15 AU AU2001284995A patent/AU2001284995B2/en not_active Ceased
- 2001-08-15 WO PCT/US2001/025701 patent/WO2002040649A1/en active IP Right Grant
- 2001-08-15 JP JP2002543646A patent/JP2005507633A/ja active Pending
-
2006
- 2006-01-04 US US11/325,764 patent/US7411043B2/en not_active Expired - Fee Related
-
2008
- 2008-07-22 US US12/177,819 patent/US7767450B2/en not_active Expired - Fee Related
-
2010
- 2010-03-09 US US12/720,461 patent/US7893209B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20090017534A1 (en) | 2009-01-15 |
EP1334178B1 (de) | 2011-09-21 |
US7893209B2 (en) | 2011-02-22 |
US7041494B2 (en) | 2006-05-09 |
CA2428350A1 (en) | 2002-05-23 |
EP2295454A1 (de) | 2011-03-16 |
WO2002040649A1 (en) | 2002-05-23 |
AU8499501A (en) | 2002-05-27 |
US20030017533A1 (en) | 2003-01-23 |
EP1334178A4 (de) | 2006-03-29 |
US7411043B2 (en) | 2008-08-12 |
US20100267930A1 (en) | 2010-10-21 |
AU2001284995B2 (en) | 2007-03-29 |
US20060099640A1 (en) | 2006-05-11 |
US7767450B2 (en) | 2010-08-03 |
WO2002040649A8 (en) | 2002-11-07 |
JP2005507633A (ja) | 2005-03-24 |
EP1334178A1 (de) | 2003-08-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69833014D1 (de) | Menschliche toll homologen | |
CY1109725T1 (el) | Ειδικες δεσμευομενες πρωτεϊνες και χρησεις αυτων | |
MXPA02011656A (es) | Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos. | |
DE60134136D1 (de) | Zytokinrezeptoruntereinheit-proteine aus säugetieren, damit zusammenhängende reagenzien und methoden | |
AU2001294541A1 (en) | Mammalian genes; related reagents and methods | |
NO2010021I1 (no) | Denosumab | |
IL172729A0 (en) | Reagents and methods for the formation of disulfide bonds and the glycosylation of proteins | |
WO2001064877A3 (en) | Human schizophrenia gene | |
DE60041697D1 (de) | Säugetier-rezeptorproteine; ähnliche reagentien und methoden | |
DE69728897D1 (de) | Saeugetierchemokine | |
WO2002026929A3 (en) | Kini-3 motor protein and methods for its use | |
EP1183330A4 (de) | Kv10.1, EIN NEUER POTENTIAL-ABHÄNGIGER KALIUMKANAL DES MENSCHLICHEN GEHIRNS | |
DE69328060D1 (de) | Angiotensin-II Typ-1 Rezeptor und dessen Herstellung | |
ATE525396T1 (de) | Slo2 und slo4, neue kaliumkanal-proteine aus menschlichem gehirn | |
ATE330011T1 (de) | Bevorzugte segmente des ntp-proteins (neural thread protein) und verfahren zu deren verwendung | |
WO2002012541A3 (en) | Novel motor proteins and methods for their use | |
WO2001096593A3 (en) | Novel motor proteins and methods for their use | |
WO2002079479A3 (en) | Motor proteins and methods for their use | |
WO2001087932A3 (en) | Seven transmembrane proteins and polynucleotides encoding the same | |
WO2003004678A3 (en) | Novel receptors | |
WO2001094417A3 (en) | Novel human seven transmembrane proteins and polynucleotides encoding the same | |
DE60321443D1 (de) | Screening-verfahren für eine prophylaktische und therapeutische Substanz für eine Nierenerkrankung | |
WO2001098314A3 (en) | Novel motor proteins and methods for their use | |
WO2003048320A3 (en) | Novel motor protein of p. falciparum and methods for its use | |
WO2002016435A3 (en) | Human 7tm proteins and polynucleotides encoding the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |